NEWS
View All-
2024.04.23
News
IRO Business Providing Total Business Solutions Starts on Full Scale
-Elimination of drug lag and drug loss, and support for foreign biotech companies entering the Japanese market- - 2024.03.21 EPS Group EPNextS Group will collaborate with Frontage Laboratories, Inc. for Early Phase Clinical Trial and Clinical Site Management in the United States to Improve “Drug Lag” and “Drug Loss” Issues in Japan.
- 2023.09.04 IR EPS Group Overview of Results for the 32nd Fiscal Year Ended September 30, 2022
- 2023.07.06 EPS Group EPS Supported Important Japan-led International Investigator-Initiated HR+/HER2- Breast Cancer Study in Asia Pacific
- 2023.06.28 IR Notice regarding acquisition of R&E Corporate Ltd (HK) and Taiga Supply Chain Management (Shenzhen) Co., Ltd. by EPS Creative Health Technology Group Limited